Back

Derivation and Validation of a Point-based Forecasting Tool for SARS-CoV-2 Critical Care Occupancy

Grima, A. A.; Lee, C. E.; Tuite, A.; Wilson, N. J.; Simmons, A. E.; Fisman, D. N.

2025-01-23 infectious diseases
10.1101/2025.01.21.25320912 medRxiv
Show abstract

BackgroundThe requirement for critical care in even a modest fraction of SARS-CoV-2 infected individuals made ICU resources an important societal chokepoint during the recent pandemic. We developed a simple regression-based point score in 2020 based on an objective of forecasting critical care occupancy in the Canadian province of Ontario based on mean age of cases, case numbers, and testing volume. Evolution of the pandemic (variants of concern, vaccination) led us to re-assess and re-calibrate our earlier work, with inclusion of information vaccination which became widespread in 2021. MethodsWe obtained complete provincial SARS-CoV-2 case, testing, and vaccination data for the period from March 2020 to September 2022, with data subdivided into 6 major "waves", following the approach applied by other Canadian investigators. Our initial model was fit only using the first two "wild type" SARS-CoV-2 waves; an updated model included wave 3 (N501Y+ variants). Our model was validated by comparing model projections to waves not used for model fitting; validation model fits were evaluated with Spearmans rho; counterfactuals without vaccination were modeled to impute fraction of critical care admissions prevented with vaccination. Costing was based on published economic estimates. ResultsOur initial model (fit to waves 1 and 2) was well calibrated (rho 0.85) but predictive validity was modest (rho 0.46). Predictive validity improved in models fit to the first 3 pandemic waves without vaccination (rho 0.60) or with vaccination (rho 0.68) (P for inclusion of vaccination 0.013 by Likelihood Ratio Test). Prevented fraction of ICU admissions attributable to vaccination was 144% (22017 admissions expected vs. 9020 observed); based on published estimates of ICU admission cost for SARS-CoV-2 the 12977 admissions averted $2.9 (CDN) billion in economic costs, in contrast to the $3 billion total cost of the vaccination program. ConclusionsSimple time series regression incorporating case and testing characteristics continues to be useful as a tool for forecasting critical care occupancy due to SARS-CoV-2 but early pandemic models need to be updated to capture the preventive effects of widespread vaccination. The economic benefit of vaccination for prevention of critical care resource consumption during the pandemic is substantial, achieving near cost neutrality with the provinces entire vaccination program.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.